Ortivus AB ser. A (ORTI-A) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.344x

Based on the latest financial reports, Ortivus AB ser. A (ORTI-A) has a cash flow conversion efficiency ratio of -0.344x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.31 Million ≈ $-786.57K USD) by net assets (Skr21.24 Million ≈ $2.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ortivus AB ser. A defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Ortivus AB ser. A - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Ortivus AB ser. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ortivus AB ser. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ortivus AB ser. A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CABASSE S.A. EO -50
F:LB0
N/A
James Cropper PLC
LSE:CRPR
0.114x
PCI-PAL PLC
LSE:PCIP
-0.753x
Premier Health of America Inc
V:PHA
-0.010x
Anexo Group Plc
LSE:ANX
-0.057x
CT UK High Income Trust Plc
LSE:CHIB
0.007x
Pebble Beach Systems Group PLC
LSE:PEB
0.760x
Quintegra Solutions Limited
NSE:QUINTEGRA
0.000x

Annual Cash Flow Conversion Efficiency for Ortivus AB ser. A (2003–2025)

The table below shows the annual cash flow conversion efficiency of Ortivus AB ser. A from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Ortivus AB ser. A.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr22.41 Million
≈ $2.41 Million
Skr-25.24 Million
≈ $-2.72 Million
-1.126x -182.77%
2024-12-31 Skr-7.17 Million
≈ $-771.07K
Skr-9.75 Million
≈ $-1.05 Million
1.360x +7869.33%
2023-12-31 Skr17.30 Million
≈ $1.86 Million
Skr-303.00K
≈ $-32.61K
-0.018x +90.98%
2022-12-31 Skr35.44 Million
≈ $3.81 Million
Skr-6.88 Million
≈ $-740.18K
-0.194x -173.52%
2021-12-31 Skr29.44 Million
≈ $3.17 Million
Skr7.77 Million
≈ $836.61K
0.264x -72.11%
2020-12-31 Skr19.68 Million
≈ $2.12 Million
Skr18.63 Million
≈ $2.00 Million
0.947x +336.12%
2019-12-31 Skr8.75 Million
≈ $942.07K
Skr-3.51 Million
≈ $-377.73K
-0.401x -71.47%
2018-12-31 Skr2.18 Million
≈ $234.71K
Skr-510.00K
≈ $-54.88K
-0.234x +69.43%
2017-12-31 Skr15.55 Million
≈ $1.67 Million
Skr-11.90 Million
≈ $-1.28 Million
-0.765x -180.94%
2016-12-31 Skr5.22 Million
≈ $561.97K
Skr4.93 Million
≈ $531.08K
0.945x +444.95%
2015-12-31 Skr12.36 Million
≈ $1.33 Million
Skr-3.39 Million
≈ $-364.50K
-0.274x -116.60%
2014-12-31 Skr19.35 Million
≈ $2.08 Million
Skr31.93 Million
≈ $3.44 Million
1.651x +498.55%
2013-12-31 Skr17.21 Million
≈ $1.85 Million
Skr-7.13 Million
≈ $-767.09K
-0.414x -244.38%
2012-12-31 Skr31.19 Million
≈ $3.36 Million
Skr8.95 Million
≈ $962.73K
0.287x +195.85%
2011-12-31 Skr29.03 Million
≈ $3.12 Million
Skr-8.69 Million
≈ $-934.97K
-0.299x +24.94%
2010-12-31 Skr66.95 Million
≈ $7.20 Million
Skr-26.69 Million
≈ $-2.87 Million
-0.399x -235.70%
2009-12-31 Skr84.63 Million
≈ $9.11 Million
Skr-10.05 Million
≈ $-1.08 Million
-0.119x +33.33%
2008-12-31 Skr106.52 Million
≈ $11.46 Million
Skr-18.98 Million
≈ $-2.04 Million
-0.178x -1980.44%
2007-12-31 Skr163.02 Million
≈ $17.54 Million
Skr-1.40 Million
≈ $-150.23K
-0.009x +95.21%
2006-12-31 Skr226.03 Million
≈ $24.32 Million
Skr-40.42 Million
≈ $-4.35 Million
-0.179x -126.19%
2005-12-31 Skr229.72 Million
≈ $24.72 Million
Skr-18.16 Million
≈ $-1.95 Million
-0.079x -131.94%
2004-12-31 Skr224.47 Million
≈ $24.16 Million
Skr55.57 Million
≈ $5.98 Million
0.248x -8.52%
2003-12-31 Skr225.09 Million
≈ $24.22 Million
Skr60.91 Million
≈ $6.55 Million
0.271x --

About Ortivus AB ser. A

ST:ORTI-A Sweden Medical Instruments & Supplies
Market Cap
$393.65K
Skr3.66 Million SEK
Market Cap Rank
#30915 Global
#732 in Sweden
Share Price
Skr2.20
Change (1 day)
-4.35%
52-Week Range
Skr1.30 - Skr3.50
All Time High
Skr33.60
About

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more